Infiltration of the skin and subcutaneous tissues with local anaesthetic solutions often produces pain and a burning discomfort which is often severe enough to be the most unpleasant part of a surgical procedure performed under local anaesthesia.' 2 There is an increasing trend for local anaesthesia (mainly peribulbar or retrobulbar injections) during cataract surgery in the UK,3 and therefore the need to relieve patient anxiety and pain is important.
Various techniques have been employed in order to reduce patient discomfort during the administration of a local anaesthetic. In ophthalmic surgery, local anaesthetic cream such as EMLA applied to the skin of the lower lid before retrobulbar injection has been shown to be beneficial in terms of pain relief during needle entry. 4 The disadvantages of this method, however, are that EMLA cream requires to be in contact with the skin for 60-90 minutes for effective anaesthesia, it can become misplaced or rubbed off, and significantly it will have no effect on the pain caused by the injection of the anaesthetic agent itself. Another method of providing a comfortable block and one which is gaining popularity in the UK, is to give a pre-injection with local anaesthetic solution diluted to 10% of the full strength with balanced salt solution.5 Amethocaine 1% drops are also commonly instilled into the conjunctival sac to provide anaesthesia before anaesthetic injection through the conjunctiva; however, this universally causes a temporary stinging discomfort to the patient.
There have been several reports in the literature suggesting that warming anaesthetic solutions reduces the pain associated with anaesthetic injection; however, much of the evidence is anecdotal and several conflicting conclusions have been drawn. There have been no published studies to examine the efficacy of this technique in ophthalmic practice and we have, therefore, designed our own double blind randomised trial to assess the potential benefit of warming 2% plain lignocaine to body temperature during peribulbar anaesthesia for cataract surgery.
Patients, materials, and methods Sixty patients undergoing routine extracapsular cataract surgery under local anaesthetic were recruited to the study. Informed consent was obtained and they were allocated randomly to receive either 2% lignocaine hydrochloride (Phoenix Pharmaceuticals Ltd, Pharma Hameln Gmbh, Germany) at room temperature (1 7-200C, 'cold') or body temperature (370C, 'warm'). There were 13 males and 17 females in the cold group with an age range of 63-101 years and a mean of 79 9 (SD 9-2) years. In the warm group there were 12 males and 18 females, with an age range of 63-92 years and a mean age of 79-8 (SD 7.1) years.
A pilot study had shown that prewarming 5 ml ampoules of lignocaine to 450C in a thermostatically controlled water bath (Grant Instruments, Cambridge) and then drawing up 8 ml into a 10 ml syringe resulted in a final temperature of 370C if the injection was given within 30-40 seconds. Room temperature vials were taken from the stock cupboard.
The study was performed double blind. The patients were unaware of the solution temperature, and the injections were all given by a single investigator who had knowledge of the solution temperatures; however, a separate investigator who was blind to the trial asked the questions relating to the pain perceived. A standard peribulbar technique was employed using a single entry site through the inferotemporal conjunctival fornix which had been anaesthetised with topical 1% amethocaine drops. In all cases 7-8 ml of 2% plain lignocaine and 150 IU of hyalase (CB Pharmaceuticals Ltd, Wrexham) in a 10 ml syringe with a 25 mm, 25 gauge sharp tipped needle (Microlance 3, 25 GI 0 5X25 No 18, Bell, Butt Becton Dickinson) was used. The needle was aimed tangentially to the globe and a periconal injection aimed into the anterior half of the orbit was made over a 30-40 second period. The commonly employed two injection technique, with a second injection into the medial compartment of the orbit was avoided to prevent possible confusioni arising between the pain of the two injections (the second injection being likely to be relatively pain free compared with the first). Patients were asked to comment on the pain of the injection rather than the needle entry.
The subjective response to pain was assessed by asking the patients to choose an integer between 0 and 10, where 0 represented no pain and 10 the worst pain imaginable. In this study lignocaine ampoules were preheated with the use ofa water bath which has the advantage of being thermostatically controlled such that desired temperatures can be preset conveniently. 'Wet' incubation, however, does carry the theoretical risk of chemical or organism contamination of the outside of the ampoules which can enter the solution on opening. Dry incubators, baby bottle warmers, and yoghurt makers are also available and used by dentists and anaesthetists, although these have the drawback ofneeding to be thermometer verified.
The study was performed 'double blind', in as far as this was possible, by having a separate investigator who was blind to the trial asking the questions relating to the pain perceived. True operator blinding was not feasible as the solution temperature could be detected through the syringe and it is conceded that this could be a source of bias -for instance, in the way the injection was administered.
The Many dental practitioners have adopted the technique of warming lignocaine to 37°C before injection; however, it has not become common practice among the medical profession. Often the patient's main fear is of the anaesthetic injection, and we have shown that patients' discomfort can be reduced by this method, thereby making these unpleasant procedures more acceptable.
